Trial Profile
A Prospective Cohort Study Evaluating the Impact of Three Progestin-based Hormonal Contraceptive (HC) Methods on Immunologic Changes in the Female Genital Tract (FGT) and Systemically
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary) ; Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms CHIME
- 15 Aug 2022 Planned End Date changed from 1 Sep 2023 to 1 Sep 2024.
- 15 Aug 2022 Planned primary completion date changed from 1 Sep 2023 to 1 Sep 2024.
- 12 Sep 2018 New trial record